Results 11 to 20 of about 16,538 (247)

A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol. [PDF]

open access: goldFront Pediatr, 2022
BackgroundNon-invasive ventilation (NIV) treatment has been developed to minimize lung damage and to avoid invasive mechanical ventilation (IMV) in preterm infants, especially in those with a gestational age of <30 weeks.
Zhang H   +6 more
europepmc   +5 more sources

High-flow nasal cannula (HFNC) vs continuous positive airway pressure (CPAP) vs nasal intermittent positive pressure ventilation as primary respiratory support in infants of ≥ 32 weeks gestational age (GA): study protocol for a three-arm multi-center randomized controlled trial. [PDF]

open access: goldTrials, 2023
Background Health problems in neonates with gestational age (GA) ≥ 32 weeks remain a major medical concern. Respiratory distress (RD) is one of the common reasons for admission of neonates with GA ≥ 32 weeks.
Zhou R   +10 more
europepmc   +4 more sources

Nasal Intermittent Positive Pressure Ventilation and Bronchopulmonary Dysplasia Among Very Preterm Infants Never Intubated During the First Neonatal Admission: A Multicenter Cohort Study. [PDF]

open access: goldFront Pediatr, 2022
IntroductionWhile non-invasive positive-pressure ventilation (NIPPV) is increasingly used as a mode of respiratory support for preterm infants, it remains unclear whether this technique translates into improved respiratory outcomes.
Avila-Alvarez A   +7 more
europepmc   +5 more sources

Nasal Intermittent Positive Pressure Ventilation for Neonatal Respiratory Distress Syndrome

open access: yesClinics in Perinatology, 2021
Nasal or noninvaisve intermittent positive pressure ventilation (NIPPV) refers to well-established noninvasive respiratory support strategies combining a continuous distending pressure with intermittent pressure increases. Uncertainty remains regarding the benefits provided by the various devices and techniques used to generate NIPPV. Our included meta-
Rueegger, CM, Owen, LS, Davis, PG
openaire   +6 more sources

17 Early nasal intermittent positive pressure ventilation versus early nasal continuous positive airway pressure for preterm infants [PDF]

open access: yesPaediatr Child Health, 2022
Abstract Background Respiratory distress syndrome (RDS) is very common in preterm infants and multiple options are available to support their breathing in the early neonatal course. Non-invasive ventilation has become widely used given the opportunity to avoid intubation, mechanical ventilation and ...
Lemyre B   +5 more
europepmc   +2 more sources

Nasal intermittent positive pressure ventilation in neonates with grade 3 bronchopulmonary dysplasia. [PDF]

open access: hybridJ Perinatol
Weems MF   +8 more
europepmc   +3 more sources

Nasal Continuous Positive Airway Pressure vs. Nasal Intermittent Positive Pressure Ventilation as Initial Treatment After Birth in Extremely Preterm Infants. [PDF]

open access: yesFront Pediatr, 2022
ObjectiveNon-invasive respiratory support strategies are known to reduce the complications of invasive mechanical ventilation in preterm infants. Nasal continuous positive airway pressure (NCPAP) and nasal intermittent positive pressure ventilation ...
Kostekci YE   +6 more
europepmc   +2 more sources

Nasal High-Frequency Oscillatory Ventilation versus Nasal Intermittent Positive Pressure Ventilation In Pre-terms With Respiratory Distress Syndrome During Early Neonatal Period: A Randomized Controlled Trial

open access: diamondPakistan Armed Forces Medical Journal, 2023
Objective: To determine the effectiveness of NHFOV versus NIPPV in reducing the need for invasive mechanical ventilation in preterm neonates with RDS (moderate-severe) during the first seven days of the life of neonate.
Rida Ali, Shahid Mahmud
openalex   +4 more sources

Home - About - Disclaimer - Privacy